Cornerstone Capital Management Holdings’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-29,100
Closed -$590K 1381
2017
Q3
$590K Buy
29,100
+7,900
+37% +$151K ﹤0.01% 1025
2017
Q2
$341K Sell
21,200
-6,500
-23% -$96K ﹤0.01% 1081
2017
Q1
$350K Sell
27,700
-202,386
-88% -$2.44M ﹤0.01% 1102
2016
Q4
$3.05M Sell
230,086
-21,700
-9% -$371K 0.02% 627
2016
Q3
$5.97M Buy
251,786
+132,479
+111% +$3.56M 0.04% 427
2016
Q2
$3.44M Buy
119,307
+98,265
+467% +$3.2M 0.03% 557
2016
Q1
$674K Sell
21,042
-59,435
-74% -$2.09M 0.01% 975
2015
Q4
$3.44M Buy
80,477
+35,275
+78% +$1.41M 0.03% 568
2015
Q3
$1.59M Sell
45,202
-9,498
-17% -$428K 0.01% 785
2015
Q2
$2.51M Sell
54,700
-27,800
-34% -$1.32M 0.02% 648
2015
Q1
$3.87M Sell
82,500
-33,800
-29% -$1.34M 0.04% 501
2014
Q4
$3.69M Sell
116,300
-18,000
-13% -$527K 0.04% 507
2014
Q3
$3.18M Buy
134,300
+92,500
+221% +$2.37M 0.03% 533
2014
Q2
$1.25M Sell
41,800
-16,800
-29% -$453K 0.01% 840
2014
Q1
$1.55M Sell
58,600
-82,065
-58% -$2.05M 0.02% 771
2013
Q4
$3.54M Sell
140,665
-35,200
-20% -$785K 0.04% 481
2013
Q3
$3.6M Sell
175,865
-34,100
-16% -$704K 0.04% 474
2013
Q2
$4.19M Buy
+209,965
New +$3.73M 0.05% 422

Other funds holding IPXL

Cornerstone Capital Management Holdings's IPXL Position: Q4 2017 in Review

Cornerstone Capital Management Holdings sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 29,100 shares — an estimated $590K sold.

Cornerstone Capital Management Holdings first reported a position in IPXL in Q2 2013 and held it in 18 quarters. The position peaked at $5.97M in Q3 2016. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • Cornerstone Capital Management Holdings reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 29,100 Impax Laboratories, Inc. shares in Q4 2017, an estimated $590K.
  • Cornerstone Capital Management Holdings first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 18 quarters.
  • Cornerstone Capital Management Holdings's Impax Laboratories, Inc. position peaked at $5.97M in Q3 2016.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.